AI Article Synopsis
- There has been a rise in implanted devices due to improved safety, broader usage, and lower costs, primarily benefiting heart rhythm stabilization.
- The devices can help identify silent arrhythmias, like atrial fibrillation (AF), in patients who may not show symptoms.
- The review focuses on whether clinicians should take action on AF identified by devices and how this information could influence anticoagulation treatment strategies.
Article Abstract
In recent years, there has been a significant increase in the number of devices implanted following improvement in their safety profile, extension of indications and reduction in cost. Although the reason remains largely the beneficial effect on heart rhythm stabilisation, implanted devices might also have additional advantages, notably identification of silent arrhythmia. Should clinicians therefore act on device-identified atrial fibrillation (AF) and should such identification be used to guide anticoagulation management? This review evaluates the current evidence on the management of device-identified asymptomatic AF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2016.01.040 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!